Liztox 100units
Pharmaceutical-grade Neurotoxin with 99.8% Purity for Aesthetic & Therapeutic Applications
Advanced Purification Technology & Medical Grade Standard
Liztox utilizes proprietary purification technology (US Patent No. 9,447,214) to produce botulinum toxin type A from Clostridium Botulinum CBFC26 strain under strict cGMP conditions. Through 22-step purification process achieving 0.1μm filtration, the final product contains 99.8% pure 900kDa neurotoxin complex with precisely calibrated biological activity of 100 units/vial. Clinical studies demonstrate onset of action within 72 hours and duration of effect averaging 3-6 months depending on injection protocol.
Clinically Validated Benefits
Wrinkle Reduction
Reduces dynamic wrinkles by 89% in glabellar lines (4-week RCT, n=320)
Hyperhidrosis Control
Decreases axillary sweating by 94% lasting 6.8 months average
Blepharospasm Relief
Reduces involuntary blinking episodes by 82% in essential blepharospasm
Precision Duration
Maintains consistent neuromuscular blockade for 120±14 days
Pharmaceutical Specifications
- Active Substance: Botulinum Toxin Type A 100 units/vial
- Strain: Clostridium Botulinum CBFC26
- Purity: 99.8% by HPLC analysis
- Molecular Weight: 900kDa complex
- Packaging: 1 lyophilized vial + 2ml sterile saline
- Storage: -5°C to -20°C protected from light
Clinical Protocol
- Reconstitution: Use preservative-free 0.9% NaCl only
- Dilution: 2.5ml for 4U/0.1ml concentration
- Injection Technique: IM using 30-32G needle
- Dosing: 20-60U per treatment area
- Onset: 3-7 days post-injection
- Duration: 3-6 months effect
Therapeutic Applications
Glabellar Lines
Standard dose: 20-30U divided across 5 injection points. Maintain 1cm supraorbital margin. Results visible within 4 days, peak at 2 weeks.
Axillary Hyperhidrosis
50U per axilla via 10-15 intradermal injections (2U per point). Anhidrosis achieved in 92% patients lasting 6.5 months.
Blepharospasm
1.25-2.5U per eyelid quadrant (total 15-50U). Inject medial to lateral avoiding levator palpebrae.
Important Clinical Notice
Notice: Therapeutic outcomes may vary significantly based on individual neuromuscular biology, injection technique, and dosage precision. Results can differ by ±30% between patients. All treatments must be administered by board-certified dermatologists or plastic surgeons. Absolute contraindications include: pregnancy, myasthenia gravis, aminoglycoside therapy, and hypersensitivity to botulinum toxins.
This product is not FDA-approved for all indications in all markets. Proper storage, handling and reconstitution are critical for maintaining potency. Monitor for ptosis, dysphagia or systemic effects. Not for self-administration under any circumstances.
Lindsey Haramoto –
excellent post.Never knew this, thankyou for letting me know.
drover sointeru –
I love it when people come together and share opinions, great blog, keep it up.
Gabriel Grassi –
Excellent site. A lot of useful info here. I am sending it to a few pals ans additionally sharing in delicious. And certainly, thanks on your effort!
Joel Athan –
Useful info. Lucky me I found your site accidentally, and I am stunned why this twist of fate did not came about in advance! I bookmarked it.
vorbelutrioperbir –
Thanks for a marvelous posting! I definitely enjoyed reading it, you’re a great author.I will ensure that I bookmark your blog and definitely will come back later in life. I want to encourage yourself to continue your great job, have a nice afternoon!
tlover tonet –
Very interesting info!Perfect just what I was looking for!